Patient preferences in treatment options of ulcerative colitis: a discrete choice experiment
T Straatmijer, ME van den Akker-van Marle… - Scandinavian journal …, 2024 - Taylor & Francis
Introduction Since the number of medical treatment options for Ulcerative Colitis (UC) has
expanded over the last decades, patients and physicians face challenges regarding …
expanded over the last decades, patients and physicians face challenges regarding …
Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
DA Marshall, KV MacDonald, D Kao… - … in Chronic Disease, 2024 - journals.sagepub.com
Background: Fecal microbiota transplantation (FMT) is a promising treatment for active
ulcerative colitis (UC). Understanding patient preferences can identify treatment features that …
ulcerative colitis (UC). Understanding patient preferences can identify treatment features that …
Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice …
G Fiorino, N Bent-Ennakhil, P Varriale… - Inflammatory Bowel …, 2024 - academic.oup.com
Background Inflammatory bowel disease requires long-term treatment; therefore,
understanding patient preferences is important in aiding informed treatment decision …
understanding patient preferences is important in aiding informed treatment decision …
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study
JP Gisbert, S Schreiber, CA Siegel… - Inflammatory Bowel …, 2024 - academic.oup.com
Background To help navigate the complex treatment landscape of ulcerative colitis (UC), we
quantified the benefit-risk trade-offs that patients were willing to make when choosing …
quantified the benefit-risk trade-offs that patients were willing to make when choosing …
[HTML][HTML] Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study.
E Coates, N Wickramasekera, A Barr… - Health Technology …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Corticosteroids are a mainstay of the treatment of moderately severe
relapses of ulcerative colitis, yet almost 50% of patients do not respond fully to these and risk …
relapses of ulcerative colitis, yet almost 50% of patients do not respond fully to these and risk …
[HTML][HTML] Patient preferences for advanced therapies in ulcerative colitis using conjoint analysis
T Kobayashi, N Mizuno, N Sato, Y Kawaguchi… - Intestinal …, 2024 - irjournal.org
Background/Aims Selecting an optimal advanced therapy for ulcerative colitis (UC) is difficult
because of the increasing number of available therapies. This study assessed UC patients' …
because of the increasing number of available therapies. This study assessed UC patients' …
Patient and Healthcare Professional Satisfaction, Acceptability, and Preference Experiences With Mirikizumab Administration for Ulcerative Colitis: An International …
D Clemow, C Radawski, J Milata, K Alaka… - Crohn's & Colitis …, 2024 - academic.oup.com
Background There is a need to better understand ulcerative colitis (UC) patient and
healthcare provider (HCP) treatment satisfaction, acceptability, and preferences. Methods …
healthcare provider (HCP) treatment satisfaction, acceptability, and preferences. Methods …
'Optimum'strategy and outcome in Crohn's anal fistula.
MJ Lee - Colorectal Disease, 2023 - search.ebscohost.com
Abstract Development and initial psychometric validation of a patient-reported outcome
measure for Crohn's perianal fistula: the Crohn's Anal Fistula Quality of Life (CAF-QoL) …
measure for Crohn's perianal fistula: the Crohn's Anal Fistula Quality of Life (CAF-QoL) …
[PDF][PDF] Patient and Healthcare Professional Satisfaction, Acceptability, and Preference Experiences with Mirikizumab Administration for Ulcerative Colitis: an …
TH Gibble, A Schaum, O Ezennia, N Martinez - 2024 - szalokitibor.hu
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2024. Published by Oxford
University Press on behalf of Crohn's & Colitis Foundation. This is an Open Access article …
University Press on behalf of Crohn's & Colitis Foundation. This is an Open Access article …